Europace

Article	Citations
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation	512
Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF)	150
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy	148
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of gen	140
Deep learning and the electrocardiogram: review of the current state-of-the-art	124
How to use digital devices to detect and manage arrhythmias: an EHRA practical guide	122
Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation	115
Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)	106
EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rh	102
Pulsed field ablation selectively spares the oesophagus during pulmonary vein isolation for atrial fibrillation	96
The V6-V1 interpeak interval: a novel criterion for the diagnosis of left bundle branch capture	94
EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS	93
EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association	92
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference	76
Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-T	75
‘Hot phase’ clinical presentation in arrhythmogenic cardiomyopathy	73
Cardiac resynchronization therapy via left bundle branch pacing vs. optimized biventricular pacing with adaptive algorithm in heart failure with left bundle branch block: a prospective, multi-centre,	72
Standardized pulmonary vein isolation workflow to enclose veins with contiguous lesions: the multicentre VISTAX trial	69
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement	67
High-power short duration vs. conventional radiofrequency ablation of atrial fibrillation: a systematic review and meta-analysis	63
Quality indicators for the care and outcomes of adults with atrial fibrillation	62
Implementation of an on-demand app-based heart rate and rhythm monitoring infrastructure for the management of atrial fibrillation through teleconsultation: TeleCheck-AF	59
Oesophageal Probe Evaluation in Radiofrequency Ablation of Atrial Fibrillation (OPERA): results from a prospective randomized trial	59
Corrigendum to: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation	58
EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry	57

The European TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic: centre and patient experiences	54
Accuracy of left atrial fibrosis detection with cardiac magnetic resonance: correlation of late gadolinium enhancement with endocardial voltage and conduction velocity	50
Pulsed field ablation prevents chronic atrial fibrotic changes and restrictive mechanics after catheter ablation for atrial fibrillation	49
The feasibility and safety of left bundle branch pacing vs. right ventricular pacing after mid-long-term follow-up: a single-centre experience	49
Electrocardiographic findings at presentation and clinical outcome in patients with SARS-CoV-2 infection	49
Randomized comparison of oesophageal protection with a temperature control device: results of the IMPACT study	47
Long-term performance and risk factors analysis after permanent His-bundle pacing and atrioventricular node ablation in patients with atrial fibrillation and heart failure	46
Epidemiology of cardiac implantable electronic device infections: incidence and risk factors	46
Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial	44
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis	43
Association between sodium–glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials	42
Mobile health applications for the detection of atrial fibrillation: a systematic review	41
Local catheter impedance drop during pulmonary vein isolation predicts acute conduction block in patients with paroxysmal atrial fibrillation: initial results of the LOCALIZE clinical trial	41
Predictive role of atrial fibrillation in cognitive decline: a systematic review and meta-analysis of 2.8 million individuals	40
Clinical characteristics and risk stratification of desmoplakin cardiomyopathy	40
Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalizations: results from the SELENE HF study	40
Safety of very high-power short-duration radiofrequency ablation for pulmonary vein isolation: a two-centre report with emphasis on silent oesophageal injury	40
Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE V	40
Efficacy and safety of ablation index-guided catheter ablation for atrial fibrillation: an updated meta-analysis	40
Conduction system pacing in everyday clinical practice: EHRA physician survey	40
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference	40
Efficacy of high-power and short-duration ablation in patients with atrial fibrillation: a prospective randomized controlled trial	40
EHRA clinical consensus statement on conduction system pacing implantation: executive summary. Endorsed by the Asia-Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS) and Latin	39
Risk stratification of patients undergoing transvenous lead extraction with the ELECTRa Registry Outcome Score (EROS): an ESC EHRA EORP European lead extraction ConTRolled ELECTRa registry analysis	38
Management of ventricular electrical storm: a contemporary appraisal	37
Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper	37
Pulmonary vein isolation alone vs. more extensive ablation with defragmentation and linear ablation of persistent atrial fibrillation: the EARNEST-PVI trial	37
CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: an international Registry	37
Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: Proceedings of the European Society of Cardiology Cardiovascular Round Table	37
Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation	36
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study	36
Novel left ventricular cardiac synchronization: left ventricular septal pacing or left bundle branch pacing?	35
Findings from repeat ablation using high-density mapping after pulmonary vein isolation with pulsed field ablation	35
Targeting non-pulmonary vein triggers in persistent atrial fibrillation: results from a prospective, multicentre, observational registry	34
Radiofrequency ablation: technological trends, challenges, and opportunities	34
Personalized paroxysmal atrial fibrillation ablation by tailoring ablation index to the left atrial wall thickness: the ‘Ablate by-LAW’ single-centre study—a pilot study	33
Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study	33
Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2019	33
How does the level of pulmonary venous isolation compare between pulsed field ablation and thermal energy ablation (radiofrequency, cryo, or laser)?	32
Incidence, epidemiology, diagnosis and prognosis of atrio-oesophageal fistula following percutaneous catheter ablation: a French nationwide survey	32
Long-term clinical impact of permanent pacemaker implantation in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis	32
Critical appraisal of technologies to assess electrical activity during atrial fibrillation: a position paper from the European Heart Rhythm Association and European Society of Cardiology Working Grou	32
The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey	32
Worldwide sedation strategies for atrial fibrillation ablation: current status and evolution over the last decade	31
Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study	31
Very high-power short-duration ablation for pulmonary vein isolation utilizing a very-close protocol—the FAST AND FURIOUS PVI study	31
Usefulness of post-procedural heart rate response to predict syncope recurrence or positive head up tilt table testing after cardioneuroablation	31
EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm S	31
Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices: a position paper by EHRA/HRS/LAHRS/APHRS	31
Reconstruction of three-dimensional biventricular activation based on the 12-lead electrocardiogram via patient-specific modelling	31

Current perspectives on wearable rhythm recordings for clinical decision-making: the wEHRAbles 2 survey	30
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)	30
Cardiac operations and interventions during the COVID-19 pandemic: a nationwide perspective	30
Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker	30
Does isolation of the left atrial posterior wall using cryoballoon ablation improve clinical outcomes in patients with persistent atrial fibrillation? A prospective randomized controlled trial	29
Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope	29
Optimizing cryoballoon pulmonary vein isolation: lessons from >1000 procedures— the Frankfurt approach	29
Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future	29
HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic	29
Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial	29
ESC working group on cardiac cellular electrophysiology position paper: relevance, opportunities, and limitations of experimental models for cardiac electrophysiology research	29
Randomized study defining the optimum target interlesion distance in ablation index-guided atrial fibrillation ablation	28
Remote monitoring of cardiac implanted electronic devices: legal requirements and ethical principles - ESC Regulatory Affairs Committee/EHRA joint task force report	28
Conduction system pacing, a European survey: insights from clinical practice	28
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care	28
The bidirectional interaction between atrial fibrillation and heart failure: consequences for the management of both diseases	28
Risk factor management and atrial fibrillation	27
Efficacy and safety of left atrial appendage electrical isolation during catheter ablation of atrial fibrillation: an updated meta-analysis	27
Outcomes after cryoballoon ablation of paroxysmal atrial fibrillation with the PolarX or the Arctic Front Advance Pro: a prospective multicentre experience	27
Brugada syndrome and syncope: a practical approach for diagnosis and treatment	27
His bundle pacing capture threshold stability during long-term follow-up and correlation with lead slack	27
European experience with a first totally leadless cardiac resynchronization therapy pacemaker system	27
Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects	26
Progressive involvement of cardiac conduction system in paediatric patients with Kearns–Sayre syndrome: how to predict occurrence of complete heart block and sudden cardiac death?	26
Cardiac ablation with pulsed electric fields: principles and biophysics	26
Relationship between procedural volume and complication rates for catheter ablation of atrial fibrillation: a systematic review and meta-analysis	26
Likelihood of injury due to vasovagal syncope: a systematic review and meta-analysis	26
Comparison of methods for delivering cardiac resynchronization therapy: an acute electrical and haemodynamic within-patient comparison of left bundle branch area, His bundle, and biventricular pacing	26
The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review	26
Inflammation and adiposity: new frontiers in atrial fibrillation	25
First experience with pulsed field ablation as routine treatment for paroxysmal atrial fibrillation	25
Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings	25
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study	25
Personalized ablation vs. conventional ablation strategies to terminate atrial fibrillation and prevent recurrence	25
Investigation on Sudden Unexpected Death in the Young (SUDY) in Europe: results of the European Heart Rhythm Association Survey	25
Frequency of injuries associated with syncope in the prevention of syncope trials	24
Pulsed field ablation using focal contact force-sensing catheters for treatment of atrial fibrillation: acute and 90-day invasive remapping results	24
Obstructive sleep apnoea testing and management in atrial fibrillation patients: a joint survey by the European Heart Rhythm Association (EHRA) and the Association of Cardiovascular Nurses and Allied	24
Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe	24
Loss-of-function mutations in cardiac ryanodine receptor channel cause various types of arrhythmias including long QT syndrome	24
Catheter ablation improves cardiovascular outcomes in patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials	24
Anatomical-based percutaneous left stellate ganglion block in patients with drug-refractory electrical storm and structural heart disease: a single-centre case series	24
Using a smartwatch electrocardiogram to detect abnormalities associated with sudden cardiac arrest in young adults	24
Novel cryoballoon ablation system for pulmonary vein isolation: multicenter assessment of efficacy and safety—ANTARCTICA study	23
The evolution of cardiac resynchronization therapy and an introduction to conduction system pacing: a conceptual review	23
2023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic	23
Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL study	23
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries	23
Reduction in new cardiac electronic device implantations in Catalonia during COVID-19	23
Infanticide vs. inherited cardiac arrhythmias	23
Predictive role of early recurrence of atrial fibrillation after cryoballoon ablation	23
Screening for atrial fibrillation: predicted sensitivity of short, intermittent electrocardiogram recordings in an asymptomatic at-risk population	23
Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study	23
Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study	22
2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment—Authors’ reply	22
Lead performance and clinical outcomes of patients with permanent His-Purkinje system pacing: a single-centre experience	22
Mobile health applications for managing atrial fibrillation for healthcare professionals and patients: a systematic review	22
Safety, effectiveness, and quality of life following pulmonary vein isolation with a multi-electrode radiofrequency balloon catheter in paroxysmal atrial fibrillation: 1-year outcomes from SHINE	22
Comparison of various late gadolinium enhancement magnetic resonance imaging methods with high-definition voltage and activation mapping for detection of atrial cardiomyopathy	22
Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score	22
A VIRTUAL Sleep Apnoea management pathway For the work-up of Atrial fibrillation patients in a digital Remote Infrastructure: VIRTUAL-SAFARI	22
Pediatric catheter ablation at the beginning of the 21st century: results from the European Multicenter Pediatric Catheter Ablation Registry ‘EUROPA’	22
Feasibility and efficacy of left bundle branch area pacing in patients indicated for cardiac resynchronization therapy	21
Age-related tilt test responses in patients with suspected reflex syncope	21
Electrocardiographic imaging for cardiac arrhythmias and resynchronization therapy	21
The effect of centre volume and procedure location on major complications and mortality from transvenous lead extraction: an ESC EHRA EORP European Lead Extraction ConTRolled ELECTRa registry subanaly	21
Predictors of recurrence of atrial fibrillation within the first 3 months after ablation	21
Identification of local atrial conduction heterogeneities using high-density conduction velocity estimation	21
Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis	21
Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death	21
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death	20
The GermAn Laser Lead Extraction RegistrY: GALLERY	20
Causes, circumstances, and potential preventability of cardiac arrest in the young: insights from a state-wide clinical and forensic registry	20
Evidence-based insights on ideal blanking period duration following atrial fibrillation catheter ablation	20
STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and re	20
Atrial fibrillation burden during the coronavirus disease 2019 pandemic	19
Smartphone electrocardiogram for detecting atrial fibrillation after a cerebral ischaemic event: a multicentre randomized controlled trial	19
Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis	19
Electrocardiographic predictors of infrahissian conduction disturbances in myotonic dystrophy type 1	19
Early atrial fibrillation detection and the transition to comprehensive management	19

Focal Impulse and Rotor Modulation Ablation vs. Pulmonary Vein isolation for the treatment of paroxysmal Atrial Fibrillation: results from the FIRMAP AF study	19
High-degree atrioventricular block in COVID-19 hospitalized patients	19
Long-term observation of catheter ablation vs. pharmacotherapy in the management of persistent and long-standing persistent atrial fibrillation (CAPA study)	19
Screen-detected atrial fibrillation predicts mortality in elderly subjects	19
Effect of remote monitoring on clinical outcomes in European heart failure patients with an implantable cardioverter-defibrillator: secondary results of the REMOTE-CIED randomized trial	19
The blanking period after atrial fibrillation ablation: an European Heart Rhythm Association survey on contemporary definition and management	19
Idiopathic ventricular fibrillation: the ongoing quest for diagnostic refinement	19
Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide	19
The use of social media for professional purposes by healthcare professionals: the #intEHRAct survey	19
Increased beat-to-beat variability of cerebral microcirculatory perfusion during atrial fibrillation: a near-infrared spectroscopy study	19
Prediction of occult atrial fibrillation in patients after cryptogenic stroke and transient ischaemic attack: PROACTIA	19
The digital journey: 25 years of digital development in electrophysiology from an Europace perspective	18
Ventricular arrhythmias in arrhythmic mitral valve syndrome—a prospective continuous long-term cardiac monitoring study	18
Diagnostic yield and accuracy in a tertiary referral syncope unit validating the ESC guideline on syncope: a prospective cohort study	18
Bipolar ablation of therapy-refractory ventricular arrhythmias: application of a dedicated approach	18
Severe acute kidney injury related to haemolysis after pulsed field ablation for atrial fibrillation	18
Low-voltage area substrate modification for atrial fibrillation ablation: a systematic review and meta-analysis of clinical trials	18
Clinical outcomes and programming strategies of implantable cardioverter-defibrillator devices in paediatric hypertrophic cardiomyopathy: a UK National Cohort Study	18
Improved prediction of sudden cardiac death in patients with heart failure through digital processing of electrocardiography	18
Procedural efficiencies, lesion metrics, and 12-month clinical outcomes for Ablation Index-guided 50 W ablation for atrial fibrillation	18
Machine learning in sudden cardiac death risk prediction: a systematic review	18
Pulmonary vein isolation with the radiofrequency balloon catheter: a single centre prospective study	18
Acute safety, efficacy, and advantages of a novel cryoballoon ablation system for pulmonary vein isolation in patients with paroxysmal atrial fibrillation: initial clinical experience	18
Progress in atrial fibrillation ablation during 25 years of Europace journal	18
Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA	18
Diagnostic yield and financial implications of a nationwide electrocardiographic screening programme to detect cardiac disease in the young	18
Miniseries 1—Part III: ‘Behind the scenes’ in the triangle of Koch	18
Acute oesophageal safety of high-power short duration with 50 W for atrial fibrillation ablation	18
Cryoballoon vs. radiofrequency catheter ablation: insights from NOrwegian randomized study of PERSistent Atrial Fibrillation (NO-PERSAF study)	18
Pulsed electric field, cryoballoon, and radiofrequency for paroxysmal atrial fibrillation ablation: a propensity score-matched comparison	18
A unified theory for the circuit of atrioventricular nodal re-entrant tachycardia	18
A meta-analysis of clinical risk factors for stroke in anticoagulant-naïve patients with atrial fibrillation	18
Myocardial infarction or acute coronary syndrome with non-obstructive coronary arteries and sudden cardiac death: a missing connection	17
Human biventricular electromechanical simulations on the progression of electrocardiographic and mechanical abnormalities in post-myocardial infarction	17
Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal	17
Budget impact analysis of a machine learning algorithm to predict high risk of atrial fibrillation among primary care patients	17
A randomized study of yoga therapy for the prevention of recurrent reflex vasovagal syncope	17
Self-reported treatment burden in patients with atrial fibrillation: quantification, major determinants, and implications for integrated holistic management of the arrhythmia	17
Endomysial fibrosis, rather than overall connective tissue content, is the main determinant of conduction disturbances in human atrial fibrillation	17
Magnetic resonance assessment of left atrial scar formation following a novel very high-power short-duration workflow for atrial fibrillation ablation	17
Twitter for professional use in electrophysiology: practical guide for #EPeeps	17
Avoiding implant complications in cardiac implantable electronic devices: what works?	17
Higher power short duration vs. lower power longer duration posterior wall ablation for atrial fibrillation and oesophageal injury outcomes: a prospective multi-centre randomized controlled study (Hi-	17
Cardiovascular magnetic resonance determinants of ventricular arrhythmic events after myocardial infarction	17
Remote monitoring data from cardiac implantable electronic devices predicts all-cause mortality	17
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm	17
European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European H	17
The influence of atrial high-rate episodes on stroke and cardiovascular death: an update	17
Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysis	17
Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fraction	17
New-onset atrial fibrillation following left bundle branch area pacing vs. right ventricular pacing: a two-centre prospective cohort study	17
Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis	17
Knowledge gaps, lack of confidence, and system barriers to guideline implementation among European physicians managing patients with CIED lead or infection complications: a European Heart Rhythm Assoc	16
Catheter ablation vs. antiarrhythmic drugs as ‘first-line’ initial therapy for atrial fibrillation: a pooled analysis of randomized data	16
Enrichment of loss-of-function and copy number variants in ventricular cardiomyopathy genes in ‘lone’ atrial fibrillation	16
Adopting permanent His bundle pacing: learning curves and medium-term outcomes	16
Prediction of thromboembolic events and mortality by the CHADS2 and the CHA2DS2-VASc in COVID-19	16
Ventricular arrhythmia risk is associated with myocardial scar but not with response to cardiac resynchronization therapy	16
Electrical markers and arrhythmic risk associated with myocardial fibrosis in mitral valve prolapse	16
Sinus rhythm voltage fingerprinting in patients with mitral valve disease using a high-density epicardial mapping approach	16
Prevalence of asystole during tilt test-induced vasovagal syncope may depend on test methodology	16
Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey	16
Single shot electroporation of premature ventricular contractions from the right ventricular outflow tract	16
Long-term outcomes in a randomized controlled trial of multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy	16
C-reactive protein after coronary artery bypass graft surgery and its relationship with postoperative atrial fibrillation	16
AFA-Recur: an ESC EORP AFA-LT registry machine-learning web calculator predicting atrial fibrillation recurrence after ablation	16
Management of ventricular tachycardia in patients with ischaemic cardiomyopathy: contemporary armamentarium	16
An artificial intelligence–based model for prediction of atrial fibrillation from single-lead sinus rhythm electrocardiograms facilitating screening	16
Prevention of cardiac implantable electronic device infections: guidelines and conventional prophylaxis	16
Sleep apnoea has a dose-dependent effect on atrial remodelling in paroxysmal but not persistent atrial fibrillation: a high-density mapping study	16
Scar conducting channel characterization to predict arrhythmogenicity during ventricular tachycardia ablation	16
Validation of a multipolar pulsed-field ablation catheter for endpoint assessment in pulmonary vein isolation procedures	16
Atrial fibrillation progression and the importance of early treatment for improving clinical outcomes	16
Epicardial adipose tissue modulates arrhythmogenesis in right ventricle outflow tract cardiomyocytes	16
Accuracy of electroanatomical mapping-guided cardiac radiotherapy for ventricular tachycardia: pitfalls and solutions	16
Long-term impact of the burden of new-onset atrial fibrillation in patients with acute myocardial infarction: results from the NOAFCAMI-SH registry	15
Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial	15
Atrial fibrillation and the risk of ischaemic strokes or intracranial haemorrhages: comparisons of the catheter ablation, medical therapy, and non-atrial fibrillation population	15
Utilization and perception of same-day discharge in electrophysiological procedures and device implantations: an EHRA survey	15
Left atrial fibrosis predicts left ventricular ejection fraction response after atrial fibrillation ablation in heart failure patients: the Fibrosis-HF Study	15
Prediction of low-voltage areas using modified APPLE score	15
Association between left atrial epicardial fat, left atrial volume, and the severity of atrial fibrillation	15
Carbon footprint of atrial fibrillation catheter ablation	15
Efficacy and safety of same-day discharge after atrial fibrillation ablation compared with post-procedural overnight stay: a systematic review and meta-analysis	15
Reimbursement practices for use of digital devices in atrial fibrillation and other arrhythmias: a European Heart Rhythm Association survey	15
Effect of alcohol consumption on the risk of adverse events in atrial fibrillation: from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)	15
Timing of cardiac resynchronization therapy implantation	15
Prevalence and clinical significance of isolated low QRS voltages in young athletes	15
Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation	15
Rate control drugs differ in the prevention of progression of atrial fibrillation	15
The SIDECAR project: S-IcD registry in European paediatriC and young Adult patients with congenital heaRt defects	15
Risk of ventricular arrhythmia in cardiac resynchronization therapy responders and super-responders: a systematic review and meta-analysis	15
Atrial fibrillation burden: an update—the need for a CHA2DS2-VASc-AFBurden score	15
Magnetic resonance-guided re-ablation for atrial fibrillation is associated with a lower recurrence rate: a case–control study	15
Life-threatening arrhythmias with autosomal recessive TECRL variants	15